Remission of anti-tumor necrosis factor-α antibody-induced palmoplantar pustulosis with the Janus kinase inhibitor baricitinib in a patient with rheumatoid arthritis

被引:3
|
作者
Imafuku, Shinichi [1 ]
Maeyama, Akira [2 ]
机构
[1] Fukuoka Univ, Fac Med, Dept Dermatol, Fukuoka, Japan
[2] Fukuoka Univ, Fac Med, Dept Orthoped Surg, Fukuoka, Japan
来源
JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 05期
关键词
D O I
10.1111/1346-8138.15860
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E240 / E241
页数:2
相关论文
共 50 条
  • [31] Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor- inhibitor therapy
    Chung, Catherine G.
    Rosengrant, Abric
    Helm, Klaus F.
    Shupp, David L.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (11) : 1294 - 1296
  • [32] Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis
    Favalli, EG
    Arreghini, M
    Arnoldi, C
    Panni, B
    Marchesoni, A
    Tosi, S
    Pontikaki, I
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 301 - 302
  • [33] Should anti-tumor necrosis factor-α be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua, C
    Gonzalez-Gay, MA
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 433 - 433
  • [34] Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide -: Role of tumor necrosis factor-α
    Huugen, D
    Xiao, H
    van Esch, A
    Falk, RJ
    Peutz-Kootstra, CJ
    Buurman, WA
    Tervaert, JWC
    Jennette, JC
    Heeringa, P
    AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (01): : 47 - 58
  • [35] Anti-tumor Necrosis Factor-induced Palmoplantar Psoriasis: Case Series
    Altalhab, Saad
    JOURNAL OF DERMATOLOGY DERMATOLOGIC SURGERY-JDDS, 2018, 22 (01): : 36 - 38
  • [36] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [37] Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis
    Ziolkowska, M
    Maslinski, W
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 267 - 273
  • [38] Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α
    Onishi, Sachiko
    Yoshio, Taku
    Nagashima, Takao
    Minota, Seiji
    MODERN RHEUMATOLOGY, 2010, 20 (05) : 528 - 530
  • [39] Improvement of nail lesions in a patient with psoriatic arthritis by switching the treatment from an anti-interleukin-17A antibody to an anti-tumor necrosis factor-α antibody
    Komatsu-Fujii, Takayoshi
    Honda, Tetsuya
    Otsuka, Atsushi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2019, 46 (05): : E158 - E160
  • [40] Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?
    Altschuler, EL
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 2000, 22 (11): : 1007 - 1008